Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Journal of Genetic Disorders & Genetic ReportsISSN: 2327-5790
Zhou Q Author
Subjects of specialization
Affiliation
Nasopharyngeal carcinoma
Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, PR China
Biography
Mr. Zhou Q, belongs to the department of Radiation and Medical Oncology, interest in the field of Nasopharyngeal carcinoma; PD-1; PD-L1; EBV; Immunotherapy, from Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, PR China
Publications
Review Article Open Access
Advances of Programmed Death-1/Programmed Death-1 Ligand Signal Pathway and its Blockers in Nasopharyngeal Carcinoma
Author(s): Zhou Q, Assani G, Ling H, Xiong Y and Zhou Y
Nasopharyngeal carcinoma is one of the most common malignancies of head and neck squamous cell carcinoma in southern China and is closely related to Epstein-Barr virus infection. Although the treatment efficacy of nasopharyngeal carcinoma has been made an obvious progress during the recent years, there are still some patients suffering from relapse or metastasis, which remains a difficult condition to manage. Recently, immunotherapy targeting programmed death-1/programmed death-1 ligand signal pathway has made a remarkable breakthrough in the treatment of many solid tumors including head and neck squamous cell carcinoma, which could be a new treatment after surgery, radiotherapy, chemotherapy and targeted therapy. Even though lots of clinical trials targeting programmed death-1/programm... view more»
Google Scholars / Researchers Sites
